Research Article
The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
Table 1
Characteristics of included subjects.
| | Characteristic | ACE/ARB exposed () | Other antihypertensives () | Healthy nonexposed () | value |
| | Age ()* | | | |
0.18
| | Gravidity (%)† | | | | | 1
2
≥3 | 41 (29.7)
39 (28.3)
58 (42.0) | 31 (28.2)
41 (37.3)
38 (34.5) | 41 (29.7)
41 (29.7)
56 (40.6) | 0.60 | | Parity (%)† | | | | | 0
1
≥2 | 59 (42.7)
38 (27.5)
41 (29.7) | 44 (40.0)
46 (41.8)
20 (18.2) | 57 (41.3)
47 (34.1)
34 (24.6) | 0.13 | | Previous miscarriage (%)† | | | | | 0
1
≥2 | 110 (79.7)
17 (12.3)
11 (8.0) | 81 (73.6)
22 (20.0)
7 (6.4) | 105 (76.1)
21 (15.2)
12 (8.7) | 0.54 | | Previous elective abortions (%)† | | | | | 0
≥1 | 119 (86.2)
19 (13.8) | 103 (93.6)
7 (6.4) | 123 (89.1)
15 (10.9) | 0.27 | | Gestational age at call ()‡ | | | | 0.09 | | Alcohol† | | | | | No
Light | 114 (85.1)
20 (14.9) | 100 (90.1)
11 (9.9) | 125 (90.6)
13 (9.4) | 0.30 | | Smoking† | | | | | No
Yes | 117 (88.0)
16 (12.0) | 102 (93.6)
7 (6.4) | 129 (93.5)
9 (6.5) | 0.18 |
|
|
*One-way Anova, †chi-square test, ‡one-way Anova on ranks.
|
